News

IN THE NEWS

Ferrer makes noise about shortcomings of pulmonary hypertension diagnostic, treatment pathways ntaylor Wed, 11/20/2024 – 11:46

https://www.fiercepharma.com/marketing/ferrer-makes-noise-about-shortcomings-pulmonary-hypertension-pathways

On a roll, CDMO Samsung Bio strikes $668M production tie-up with European pharma fkansteiner Wed, 11/20/2024 – 13:41

https://www.fiercepharma.com/pharma/samsung-bio-inks-production-tie-another-unnamed-pharma-time-worth-668m

Rapid growth spurt for UCB’s Bimzelx continues with hidradenitis suppurativa nod marking 5th FDA approval zbecker Wed, 11/20/2024 – 10:49

https://www.fiercepharma.com/pharma/rapid-growth-spurt-ucbs-bimzelx-continues-hidradenitis-suppurativa-nod-marking-5th-fda

Johnson & Johnson, Merck lay off workers in China as local headwinds take a toll kdunleavy Wed, 11/20/2024 – 11:02

https://www.fiercepharma.com/pharma/johnson-johnson-merck-lay-workers-china

Gilead supports creation of ‘sanctuary’ resource hub for Black triple-negative breast cancer patients apark Wed, 11/20/2024 – 10:33

https://www.fiercepharma.com/marketing/gilead-supports-creation-sanctuary-resource-hub-black-triple-negative-breast-cancer

Plasma specialist Grifols shrugs off private equity firm Brookfield’s potential €6.5B takeover offer fkansteiner Wed, 11/20/2024 – 09:59

https://www.fiercepharma.com/pharma/plasma-specialist-grifols-shrugs-private-equity-firm-brookfields-potential-eu65b-takeover